Literature DB >> 1936162

A serosurvey for HTLV-I among high-risk populations and normal adults in Egypt.

N T Constantine1, M Fathi Sheba, A L Corwin, R S Danahy, J D Callahan, D M Watts.   

Abstract

The prevalence of antibodies to human T-cell lymphotropic virus type I (HTLV-I) was determined in high-risk groups and normal adults in Egypt. Among 647 individuals tested, 6 (0.9%) were confirmed positive by western blot analysis. These included 2 (0.7%) of 279 drug addicts, 1 (3.3%) of 30 patients with sexually transmitted diseases, and 3 (2.2%) of 133 healthy individuals. Antibody was not detected in 47 blood recipients or 158 prostitutes. There was no correlation between sex or geographical location and HTLV-I infection. Fifty-three of the 647 sera (8%) were initially reactive by ELISA, but only 12 sera were repeatedly reactive. Since only 4 of these repeatedly reactive sera were confirmed by the western blot, the frequency of false positives using the DuPont screening ELISA was 1.2% (8/643). Two additional sera, confirmed positive by western blot, had been reactive, but not repeatedly, by ELISA. In comparison to the prevalence of HTLV-I antibody among risk groups in many parts of the world, the prevalence in Egypt was low.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936162      PMCID: PMC2272073          DOI: 10.1017/s0950268800049074

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  20 in total

1.  Incidence of adult T-cell leukemia-lymphoma and its familial clustering.

Authors:  T Kondo; H Nonaka; N Miyamoto; R Yoshida; Y Matsue; Y Ohguchi; H Inouye; H Komoda; Y Hinuma; M Hanaoka
Journal:  Int J Cancer       Date:  1985-06-15       Impact factor: 7.396

2.  Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region.

Authors:  M Robert-Guroff; S H Weiss; J A Giron; A M Jennings; H M Ginzburg; I B Margolis; W A Blattner; R C Gallo
Journal:  JAMA       Date:  1986-06-13       Impact factor: 56.272

3.  Human T lymphotropic virus type I infection in Papua New Guinea: high prevalence among the Hagahai confirmed by western analysis.

Authors:  R Yanagihara; C L Jenkins; S S Alexander; C A Mora; R M Garruto
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

4.  Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii.

Authors:  W A Blattner; A Nomura; J W Clark; G Y Ho; Y Nakao; R Gallo; M Robert-Guroff
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  Studies in healthy human T-cell-leukemia lymphoma virus (HTLV-I) carriers from the Caribbean.

Authors:  E Matutes; A G Dalgleish; R A Weiss; A P Joseph; D Catovsky
Journal:  Int J Cancer       Date:  1986-07-15       Impact factor: 7.396

6.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

7.  Human T-cell leukemia virus (HTLV-I) antibodies in Africa.

Authors:  W Saxinger; W A Blattner; P H Levine; J Clark; R Biggar; M Hoh; J Moghissi; P Jacobs; L Wilson; R Jacobson
Journal:  Science       Date:  1984-09-28       Impact factor: 47.728

8.  Human T-cell lymphotropic virus type I (HTLV-I) seroepidemiology and risk factors in metropolitan Panamá.

Authors:  W C Reeves; C Saxinger; M M Brenes; E Quiroz; J W Clark; M W Hoh; W A Blattner
Journal:  Am J Epidemiol       Date:  1988-03       Impact factor: 4.897

Review 9.  Adult T cell leukaemia/lymphoma.

Authors:  P R Kuefler; P A Bunn
Journal:  Clin Haematol       Date:  1986-08

10.  Prevention of HTLV-I transmission through the breast milk by a freeze-thawing process.

Authors:  Y Ando; S Nakano; K Saito; I Shimamoto; M Ichijo; T Toyama; Y Hinuma
Journal:  Jpn J Cancer Res       Date:  1986-10
View more
  1 in total

Review 1.  Seroprevalence of HTLV-1 and HTLV-2 amongst mothers and children in Malawi within the context of a systematic review and meta-analysis of HTLV seroprevalence in Africa.

Authors:  James M Fox; Nora Mutalima; Elizabeth Molyneux; Lucy M Carpenter; Graham P Taylor; Martin Bland; Robert Newton; Fabiola Martin
Journal:  Trop Med Int Health       Date:  2016-02-03       Impact factor: 2.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.